Tempest Therapeutics TPST
NASDAQ TPST
$0.39 -0.01 (-2.17%)
As of: Nov 12, 2026 · 2:18 PM EST

Tempest Therapeutics (TPST) Receivables - Other (2021 - 2023)

Updated

Tempest Therapeutics (TPST) posted Receivables - Other of $450,000 for Q4 2022, down 97.0% from $15 million a year earlier.

Analysis

Tempest Therapeutics (TPST) Receivables - Other (2021 - 2023) Analysis & Trends

  • In prior years, Tempest Therapeutics' Receivables - Other was $15 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Tempest Therapeutics 5.91 Mn -11.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 450,000.00
Dec 31, 2022 450,000.00
Sep 30, 2022 15.20 Mn
Jun 30, 2022 15.00 Mn
Mar 31, 2022 15.00 Mn
Dec 31, 2021 15.00 Mn
Mar 31, 2021 15.00 Mn
API Access

Tempest Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=TPST&period=max&api_key=YOUR_API_KEY